Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling to lessen the budgetary squeeze from fast-rising costs.
About us, Contact us, Contribute, Privacy Policy, Review Guidelines, Legal Notice, 2023 MACH MEDIA
Home » The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling to lessen the budgetary squeeze from fast-rising costs.